Get the Stockscreener App
1.37
7.43%
-0.11
After Hours:
1.41
0.04
+2.92%
Gelteq Ltd stock is traded at $1.37, with a volume of 95,203.
It is down -7.43% in the last 24 hours and up +51.88% over the past month.
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
See More
Previous Close:
$1.48
Open:
$1.44
24h Volume:
95,203
Relative Volume:
0.07
Market Cap:
$17.46M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-25.95%
1M Performance:
+51.88%
6M Performance:
-40.95%
1Y Performance:
+0.00%
1-Day Range:
$1.37
$1.51
1-Week Range:
$1.37
$1.854
52-Week Range:
$0.7701
$5.50
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
1.37 | 17.46M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Gelteq Ltd Stock (GELS) Latest News
Gelteq Ltd (GELS) Stock: A Year of Market Movement, Down and Up - investchronicle.com
Gelteq Ltd (GELS) Volatility Hits 28.96% – Here Is What You Should Do - Stocksregister
Promising Penny Stocks To Watch Now – April 22nd - Defense World
Top Biotech Stocks To Watch Today – April 22nd - Defense World
Enphase Energy Posts Downbeat Results, Joins Watsco And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
SmallCaps Gaining Momentum: TIVC, GELS, SLI, OBIO - openPR.com
SmallCaps Gaining Momentum: TIVC, GELS, SLI, OBIO in Healthcare, Biotech, Energy, Military Defense, Etc. – More Stocks Inside | FinancialContent - FinancialContent
Gelteq Ltd (GELS) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Dow Jumps Over 400 Points; Verizon Earnings Top Views - Benzinga
Sweetgreen Inc Inc. (SG) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
GELS Stock Price and Chart — NASDAQ:GELS - TradingView
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Gelteq LimitedOrdinary Shares (NQ: GELS - FinancialContent
XD Inc. (OTCMKTS:XDNCF) Short Interest Update - Defense World
Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga
CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga
Sometimes it’s not the drug, but how it’s delivered - Townsville Bulletin
Aspire Biopharma Hldgs Stock Price, Quotes and Forecasts | NASDAQ:ASBP - Benzinga
Gelteq introduces SportsGel with China deal in H1 2025 - Investing.com India
Gelteq introduces SportsGel with China deal in H1 2025 By Investing.com - Investing.com South Africa
Gelteq's Strategic Move: New Sports Nutrition Brand Takes Aim at Asia's Fastest-Growing Market - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Gelteq Appoints Matthew Jones as Head of Sports Performance - GlobeNewswire Inc.
Gelteq Taps UAE Football, Boston Celtics Nutrition Expert to Lead Sports Performance Division - StockTitan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Gelteq Strengthens Leadership with Renowned Scientist Dr. Paul Wynne as Chief Scientific Officer - StockTitan
“Gelteq has been continuously evolving to expand applications and audiences” - AlphaStreet
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug - The Manila Times
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Inkl
Oral drug and nutrient gel specialist soars after top client bumps up order by 50% - Mugglehead
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for Pancreatic Cancer Patients - BP Journal
Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic U.S. Expansion - BP Journal
The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer Treatment with CM24 - BP Journal
Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal
Stock market news: Senti Biosciences +404.62%, Fossil Group +54.11% among top gainers during mid day trading - Business Upturn
Polyrizon Ltd.’s Quiet Period To End on December 9th (NASDAQ:PLRZ) - Defense World
Gelteq Limited’s (NASDAQ:GELS) Quiet Period To End on December 9th - Defense World
Gelteq (GELS) Ramps Up Production: 400,000 Gel Units Set for Global Distribution | GELS Stock News - StockTitan
Ins & OutsWeek Ending 11/15/2024 - substack.com
Gelteq Limited Appoints Adam Bendell as President of U.S. Operations - Marketscreener.com
Gelteq (GELS) Accelerates U.S. Growth, Appoints Former Deloitte Executive as President - StockTitan
Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online
Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia
Gelteq Limited Closes US$5.2 Million Initial Public Offering - Stock Titan
Gelteq Ltd Stock (GELS) Financials Data
There is no financial data for Gelteq Ltd (GELS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.82%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):